Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Withdrawn before enrolling · Phase 3
Conditions studied: Lung Cancer
In brief
RATIONALE: Drugs used in chemotherapy such as gemcitabine, carboplatin, and paclitaxel use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective in treating non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of different combination chemotherapy regimens in treating patients who have stage IIIB, stage IV, or recurrent non-small cell lung cancer.
Key facts
- Study ID
- NCT00054392
- Run by
- Fox Chase Cancer Center
- People needed
- 0
- Starts
- 2001-09-01
- Expected to finish
- 2001-09-01
- Last updated by the study team
- 2013-07-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- New Hope Cancer and Research Institute - Pomona — Pomona, California, United States
- Lawrence and Memorial Hospital — New London, Connecticut, United States
- University of Florida Shands Cancer Center — Gainesville, Florida, United States
- Lakeland Regional Cancer Center at Lakeland Regional Medical Center — Lakeland, Florida, United States
- Gulf Coast Cancer Treatment Center — Panama City, Florida, United States
- Veterans Affairs Medical Center - Atlanta (Decatur) — Decatur, Georgia, United States
- Ingalls Cancer Care Center at Ingalls Memorial Hospital — Harvey, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital — Urbana, Illinois, United States
- Cancer Center of Indiana — New Albany, Indiana, United States
- CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
- Annapolis Oncology Center — Annapolis, Maryland, United States
- Greenebaum Cancer Center at University of Maryland Medical Center — Baltimore, Maryland, United States
- Greater Baltimore Medical Center Cancer Center — Baltimore, Maryland, United States
- Baystate Regional Cancer Program at D'Amour Center for Cancer Care — Springfield, Massachusetts, United States
- Fallon Clinic at Worcester Medical Center — Worcester, Massachusetts, United States
- West Michigan Cancer Center — Kalamazoo, Michigan, United States
- Sletten Regional Cancer Institute at Benefis Healthcare — Great Falls, Montana, United States
- Hunterdon Regional Cancer Center at Hunterdon Medical Center — Flemington, New Jersey, United States
- Study site — Howell Township, New Jersey, United States
- Jersey Shore Cancer Center at Jersey Shore University Medical Center — Neptune City, New Jersey, United States
- AtlantiCare Regional Medical Center — Pomona, New Jersey, United States
- Mercer Bucks Oncology-Hematology — Trenton, New Jersey, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center — Loma Linda, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.